Profile of paritaprevir/ritonavir/ombitasvir plus dasabuvir in the treatment of chronic hepatitis C virus genotype 1 infection.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2015
published in
has subject area
- 2-Naphthylamine
- Anilides
- Antiviral Agents
- Carbamates
- Carrier Proteins
- Cyclopropanes
- Drug Interactions
- Drug Resistance, Viral
- Drug Therapy, Combination
- Genotype
- Hepacivirus
- Hepatitis C, Chronic
- Humans
- Intracellular Signaling Peptides and Proteins
- Lactams, Macrocyclic
- Macrocyclic Compounds
- Molecular Targeted Therapy
- Proline
- Protease Inhibitors
- Ritonavir
- Sulfonamides
- Treatment Outcome
- Uracil
- Valine
- Viral Nonstructural Proteins